Latest Close
$0.11
Stock Hub
ADIA
Adial Pharmaceuticals, Inc
Adia Med Inc operates as a clinical-stage regenerative medicine company. The company offers products and services focused on stem cell therapies, regenerative medicine treatments, and clinical research in areas such as aesthetics, orthopedics, and autoimmune diseases. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
$0.07 (+189.47%)
Market Cap
$10,384,517.00
Sector
Healthcare
Industry
Medical Care Facilities
Recommendation
none
52W Range
$0.03 to $0.28
Target Mean Price
Not available
Beta
-8.77
Trailing P/E
Not available
Forward P/E
Not available
Price / Book
Not available
Company Overview
Adia Med Inc operates as a clinical-stage regenerative medicine company. The company offers products and services focused on stem cell therapies, regenerative medicine treatments, and clinical research in areas such as aesthetics, orthopedics, and autoimmune diseases. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.